endothelin-1 and dactolisib

endothelin-1 has been researched along with dactolisib* in 1 studies

Other Studies

1 other study(ies) available for endothelin-1 and dactolisib

Article	Year
The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia. Acta pharmacologica Sinica, 2017, Volume: 38, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelin-1; Humans; Imidazoles; Leukemia, Myeloid, Acute; MicroRNAs; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases	2017

Article

Year

The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.

Acta pharmacologica Sinica, 2017, Volume: 38, Issue:3

Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelin-1; Humans; Imidazoles; Leukemia, Myeloid, Acute; MicroRNAs; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases

2017